AMY WHITLEY: Open Payments
NPI 1518460781 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 25 payments from 9 companies in 2025. Trend: 2023 $821 · 2024 $677 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $150 |
| ABBVIE INC. | 6 | $103 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, OTEZLA, MOUNJARO, INSPIRE, FARXIGA.
Industry payments across GA — which companies pay providers there.
